Matinas BioPharma Holdings (MTNB) Long-Term Debt Repayments (2013 - 2025)
Matinas BioPharma Holdings (MTNB) reported Long-Term Debt Repayments of $7,000 for Q4 2025, up 600.0% from $1,000 a year earlier.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Long-Term Debt Repayments (2013 - 2025) Analysis & Trends
For FY2025, Matinas BioPharma Holdings posted Long-Term Debt Repayments of $9,000, up 80.0% from FY2024.
- Long-Term Debt Repayments has a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- By year, Long-Term Debt Repayments came in at $5,000 in FY2024 (-28.6%), $7,000 in FY2023 (-65.0%), $20,000 in FY2022 (-33.3%) and $30,000 in FY2021 (-45.1%).
- The Q4 2025 figure ranks as the highest quarterly Long-Term Debt Repayments since Q3 2021.
- Year over year, Long-Term Debt Repayments gained in two of the last seven quarters, with growth averaging 89.3%.
- The high point for year-over-year Long-Term Debt Repayments in five years was Q4 2025 (growth of 600.0%); the low point was Q2 2023 (a decline of 83.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | - |
| 10 | Matinas BioPharma Holdings | 700,366.84 | -11.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 5,541.00 |
| Sep 30, 2021 | 8,324.00 |
| Jun 30, 2021 | 8,152.00 |
| Mar 31, 2021 | 7,983.00 |
| Dec 31, 2020 | 7,819.00 |
API Access
Matinas BioPharma Holdings Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();